Presentation Cost-Effectiveness of Apixaban vs Current Standard of Care for Stroke Prevention in A-fib Patients Presenter: Paul Dorian February 20, 2014
News Daily News Una Escala del Riesgo Predice la Mortalidad a Largo Plazo tras PCI Caitlin E. Cox February 03, 2014
News Daily News For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs July 25, 2013
Presentation Cost-Effectiveness of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation Presenter: A.R. Harrington April 05, 2013
News Conference News ACC 2013 MASS COMM: On-site Surgical Back-up Not Necessary for Elective PCI Jason Kahn March 11, 2013
News Conference News AHA 2012 AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community Jason Kahn November 11, 2012
News Daily News Model Suggests Renal Denervation Cost-effective for Resistant Hypertension September 13, 2012
News Conference News ESC 2012 Study Looks at Global Mortality, Stroke Rates in A-fib Patients After ER Visit Yael L. Maxwell August 29, 2012
News Daily News Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years Caitlin E. Cox July 12, 2012
News Daily News A los 10 Años el Apixaban resulta Más Barato que la Aspirina para la Prevención de ACV en Pacientes con FA Caitlin E. Cox July 12, 2012
Presentation Cost-Effectiveness of Apixaban vs. Aspirin for Stroke Prevention Among A-fib Pts Unsuitable for Warfarin Presenter: S. Lee July 11, 2012
News Daily News Live Case Procedures Just as Safe as in Daily Practice Caitlin E. Cox February 21, 2012
News Daily News Low US Participation in NIH-Sponsored CVD Trials Cause for Concern Jason Kahn August 01, 2011
News Daily News Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk L.A. McKeown June 03, 2011
News Daily News DES Add Over $1.5 Billion in Medicare Costs to Health Care System Jason Kahn April 28, 2011